← Back to Search

Text Message Reminders for Health Maintenance

N/A

Waitlist Available

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 week after getting the outreach text message

Awards & highlights

Study Summary

This trial tests if sending text messages can help people follow their doctor's instructions better, to help them stay healthy. #textmessagetherapy

Who is the study for?

This trial is for adults with a March, April, May or June birthday who are patients at UCLA Health DOM Primary Care. They must be able to receive SMS messages and have an active MyChart status. Participants should have overdue health maintenance measures targeted by the My Action Plan initiative but can't join if they're under 18, opted out of electronic communication, already scheduled/completed all screenings before receiving texts, or are deceased/hospice patients.Check my eligibility

What is being tested?

The study tests how different types of text messages (specific vs general) and those designed to elevate intentions or prompt action affect patient engagement in primary care. It's part of a larger effort to improve preventive care completion rates at UCLA Health.See study design

What are the potential side effects?

Since this trial involves sending text messages rather than medical treatments, there aren't traditional side effects. However, participants may experience increased communication from their healthcare provider.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 week after getting the outreach text message

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 week after getting the outreach text message

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week after getting the outreach text message for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Opening link within SMS Text message

Secondary outcome measures

Completion rate of one screening/test

Direct scheduling appointment rate

Opening My Action Plan Letter

+1 more

Trial Design

4Treatment groups

Experimental Treatment

Group I: Arm 4: Action-oriented; GeneralExperimental Treatment3 Interventions

Eligible, randomized participant will receive an action-oriented, generic SMS-message informing patients that they have a health gap to be closed and prompting them to act soon before they forget.

Group II: Arm 3: Intention-oriented; GeneralExperimental Treatment3 Interventions

Eligible, randomized participant will receive an intention-oriented, generic SMS message informing patients that they have a health gap to be closed and highlighting the importance of doing so.

Group III: Arm 2: GeneralExperimental Treatment2 Interventions

Eligible, randomized participant will receive a brief, generic SMS message informing patients that they have a health gap to be closed.

Group IV: Arm 1: SpecificExperimental Treatment2 Interventions

Eligible, randomized participant will receive a brief, specific SMS message informing patients that they should obtain screenings and tests they are due for.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

General

2015

N/A

~210

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

UCLA David Geffen School of MedicineUNKNOWN

4 Previous Clinical Trials

68,898 Total Patients Enrolled

University of California, Los AngelesLead Sponsor

1,529 Previous Clinical Trials

10,229,851 Total Patients Enrolled

UCLA Health Department of MedicineUNKNOWN

3 Previous Clinical Trials

34,046 Total Patients Enrolled

Media Library

Arm 3: Intention-oriented; General Clinical Trial Eligibility Overview. Trial Name: NCT05793788 — N/A

Cancer Research Study Groups: Arm 3: Intention-oriented; General, Arm 4: Action-oriented; General, Arm 1: Specific, Arm 2: General

Cancer Clinical Trial 2023: Arm 3: Intention-oriented; General Highlights & Side Effects. Trial Name: NCT05793788 — N/A

Arm 3: Intention-oriented; General 2023 Treatment Timeline for Medical Study. Trial Name: NCT05793788 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment offer open registration for participants?

"According to clinicaltrials.gov, no participants are being admitted into this trial which originally opened on March 9th 2023 and was recently updated at the end of that month. Nevertheless, there currently exist 687 other medical studies accepting patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

UCLA Health Patient Health Maintenance Outreach Text Message

Richard K. Leuchter, MD 2023. "UCLA Health Patient Health Maintenance Outreach Text Message". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05793788.